Proangiogenic scaffolds as functional templates for cardiac tissue engineering - PubMed (original) (raw)
Proangiogenic scaffolds as functional templates for cardiac tissue engineering
Lauran R Madden et al. Proc Natl Acad Sci U S A. 2010.
Abstract
We demonstrate here a cardiac tissue-engineering strategy addressing multicellular organization, integration into host myocardium, and directional cues to reconstruct the functional architecture of heart muscle. Microtemplating is used to shape poly(2-hydroxyethyl methacrylate-co-methacrylic acid) hydrogel into a tissue-engineering scaffold with architectures driving heart tissue integration. The construct contains parallel channels to organize cardiomyocyte bundles, supported by micrometer-sized, spherical, interconnected pores that enhance angiogenesis while reducing scarring. Surface-modified scaffolds were seeded with human ES cell-derived cardiomyocytes and cultured in vitro. Cardiomyocytes survived and proliferated for 2 wk in scaffolds, reaching adult heart densities. Cardiac implantation of acellular scaffolds with pore diameters of 30-40 microm showed angiogenesis and reduced fibrotic response, coinciding with a shift in macrophage phenotype toward the M2 state. This work establishes a foundation for spatially controlled cardiac tissue engineering by providing discrete compartments for cardiomyocytes and stroma in a scaffold that enhances vascularization and integration while controlling the inflammatory response.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Fig. 1.
Analysis of bimodal scaffolds in vitro. (A and B) SEM images of bimodal scaffolds. Final scaffold design consists of 60-μm channels spaced 60 μm apart. Channel walls contain spherical pores with a 30-μm diameter and 15-μm interconnects. Note that the dehydrated structures are ∼80% of their hydrated size. (C and D) Digital volumetric imaging shows a fiber-templated scaffold (green) seeded with primary chick cardiomyocytes (red). Seeding is uniform across the channels (C), whereas the longitudinal cross-section (D) reveals a slight gradient in cell density. (E) Chick cardiomyocyte-seeded structure with positive staining for sarcomeric myosin heavy chain (Sarc; brown). Cardiomyocytes reside predominantly within the channels, whereas noncardiomyocytes migrate throughout the pores. (F) hESC-CM–seeded scaffolds cultured for 1 wk showing a high density of β-myosin heavy chain–positive (brown) cells within the channels. This scaffold measures ∼600 μm perpendicular to the page with this section taken at the midpoint, ∼300 μm into the scaffold. (Inset) The 40× magnification image shows that cardiomyocytes at the center of the construct exhibit shrunken cytoplasm, but intact nuclei indicate viability. (G) Immunolabeling against troponin T shows the presence of contractile proteins in hESC-CM seeded in the channel constructs. (Inset) The 100× magnification of the boxed area shows troponin T–positive hESC-CM oriented along scaffold channels. (H) Confocal image obtained using a live/dead assay shows the distribution of cells relative to the channel constructs (autofluorescent in red). (Scale bars: A, 100 μm; B, 20 μm; C and D, 300 μm; E, 50 μm; F, 400 μm; G, 50 μm; H, 400 μm.)
Fig. 2.
Acellular scaffolds implanted in the nude rat myocardium for 4 wk. (A) H&E overview of the implant, scar, and surrounding myocardium. (B) The 20× magnification of the boxed area in A shows the thin scar separating the implant from host tissue. Pores are filled primarily with granulation tissue including small vessels. (C) Endothelial lumens positive for the rat endothelial cell marker RECA-1 are present in the scaffold (arrows). (D) CD68+ macrophages infiltrated porous constructs (brown staining), but porosity limited fusion to foreign body giant cells. (E–H) Trichrome staining shows the collagen capsule (blue) and surrounding myocardium (red). (E) Nonporous and (F) 60-μm porous constructs had thicker and denser capsules than (G) 30-μm and (H) 20-μm pores. Insets show 20× images of boxed areas in E–H. (Scale bars: A, 100 μm; B, 10 μm; C and D, 50 μm; E_–_H, 250 μm; Insets, 50 μm.) (I) Neovascularization was assessed by quantification of RECA-1+ lumen structures (n = 3). (J) Thickness of the fibrous capsule surrounding implants was measured (n = 3).
Fig. 3.
Evaluation of vessel functionality in 4-wk myocardial implants in Sprague-Dawley rats by biotinylated lectin perfusion. (A) Lumen structures positive for biotinylated lectin (brown staining) were identified within porous implants (arrows) and host tissue (dart). (B) Perfused biotinylated lectin (streptavidin-FITC) and endothelial cells (RECA-1) were colocalized within the scaffold. Few unperfused endothelial structures were RECA-1+/lectin− (arrow). (C) Mature vessels had RECA-1+ lumens with a smooth muscle layer positive for α-smooth muscle actin. (D) Density of functional vessels was quantified over the entire implant with 40- and 80-μm porous scaffolds having significantly higher densities than nonporous and 20-μm porous scaffolds (n = 4; *P < 0.05). (Scale bars: A, 50 μm; B and C, 20 μm.)
Fig. 4.
Macrophage phenotype in response to 4-wk myocardial implants in Sprague-Dawley rats. (A) MΦ were identified with CD68+ staining. M1 and M2 phenotypes were determined by NOS2 (B) and MMR (C), respectively. (D) Overlayed images of CD68, NOS2, and MMR were analyzed to determine MΦ phenotype. A majority of MΦ in the porous implants expressed both NOS2 and MMR, although NOS2+/MMR− (darts) and NOS2−/MMR+ (arrows) MΦ could be identified (A–D). MΦ typically adhered to the material (D, brightfield Inset). (E) The fraction of each activated state was determined for CD68+ MΦ, with significant increase in NOS2+/MMR+ MΦ at all porous implant sites (n = 4; P < 0.05). There is a trend of increased NOS2−/MMR+ MΦ in 40-μm porous constructs versus nonporous (P = 0.06). (Scale bars: A_–_D, 50 μm.)
Similar articles
- Prevascularized microtemplated fibrin scaffolds for cardiac tissue engineering applications.
Thomson KS, Korte FS, Giachelli CM, Ratner BD, Regnier M, Scatena M. Thomson KS, et al. Tissue Eng Part A. 2013 Apr;19(7-8):967-77. doi: 10.1089/ten.tea.2012.0286. Epub 2013 Jan 14. Tissue Eng Part A. 2013. PMID: 23317311 Free PMC article. - Anisotropic silk biomaterials containing cardiac extracellular matrix for cardiac tissue engineering.
Stoppel WL, Hu D, Domian IJ, Kaplan DL, Black LD 3rd. Stoppel WL, et al. Biomed Mater. 2015 Mar 31;10(3):034105. doi: 10.1088/1748-6041/10/3/034105. Biomed Mater. 2015. PMID: 25826196 Free PMC article. - Acellular cardiac extracellular matrix as a scaffold for tissue engineering: in vitro cell support, remodeling, and biocompatibility.
Eitan Y, Sarig U, Dahan N, Machluf M. Eitan Y, et al. Tissue Eng Part C Methods. 2010 Aug;16(4):671-83. doi: 10.1089/ten.TEC.2009.0111. Tissue Eng Part C Methods. 2010. PMID: 19780649 - Biophysical stimulation for in vitro engineering of functional cardiac tissues.
Korolj A, Wang EY, Civitarese RA, Radisic M. Korolj A, et al. Clin Sci (Lond). 2017 Jul 1;131(13):1393-1404. doi: 10.1042/CS20170055. Clin Sci (Lond). 2017. PMID: 28645929 Review. - [Heart valve and myocardial tissue engineering].
Cebotari S, Tudorache I, Schilling T, Haverich A. Cebotari S, et al. Herz. 2010 Aug;35(5):334-41. doi: 10.1007/s00059-010-3355-x. Herz. 2010. PMID: 20631970 Review. German.
Cited by
- Application of Pro-angiogenic Biomaterials in Myocardial Infarction.
Liang T, Liu J, Liu F, Su X, Li X, Zeng J, Chen F, Wen H, Chen Y, Tao J, Lei Q, Li G, Cheng P. Liang T, et al. ACS Omega. 2024 Aug 27;9(36):37505-37529. doi: 10.1021/acsomega.4c04682. eCollection 2024 Sep 10. ACS Omega. 2024. PMID: 39281944 Free PMC article. Review. - Effect of Scaffold Geometrical Structure on Macrophage Polarization during Bone Regeneration Using Honeycomb Tricalcium Phosphate.
Takabatake K, Tsujigiwa H, Nakano K, Chang A, Piao T, Inada Y, Arashima T, Morimatsu A, Tanaka A, Kawai H, Nagatsuka H. Takabatake K, et al. Materials (Basel). 2024 Aug 19;17(16):4108. doi: 10.3390/ma17164108. Materials (Basel). 2024. PMID: 39203286 Free PMC article. - A core-shell-type nanosystem promotes diabetic wound healing through Photothermal-responsive release of transforming growth factor β.
Hou J, Jie J, Wei X, Shen X, Zhao Q, Chai X, Pang H, Shen Z, Wang J, Wu L, Xu J. Hou J, et al. J Nanobiotechnology. 2024 Jul 30;22(1):449. doi: 10.1186/s12951-024-02675-2. J Nanobiotechnology. 2024. PMID: 39080658 Free PMC article. No abstract available. - Biocompatible adipose extracellular matrix and reduced graphene oxide nanocomposite for tissue engineering applications.
Verstappen K, Klymov A, Cicuéndez M, da Silva DM, Barroca N, Fernández-San-Argimiro FJ, Madarieta I, Casarrubios L, Feito MJ, Diez-Orejas R, Ferreira R, Leeuwenburgh SCG, Portolés MT, Marques PAAP, Walboomers XF. Verstappen K, et al. Mater Today Bio. 2024 Apr 17;26:101059. doi: 10.1016/j.mtbio.2024.101059. eCollection 2024 Jun. Mater Today Bio. 2024. PMID: 38693996 Free PMC article. - Radical Scavenging, Hemocompatibility, and Antibacterial Activity against MDR Acinetobacter baumannii in Alginate-Based Aerogels Containing Lipoic Acid-Capped Silver Nanoparticles.
Martínez-García KD, Zertuche-Arias T, Bernáldez-Sarabia J, Iñiguez E, Kretzchmar T, Camacho-Villegas TA, Lugo-Fabres PH, Licea Navarro AF, Bravo-Madrigal J, Castro-Ceseña AB. Martínez-García KD, et al. ACS Omega. 2024 Jan 3;9(2):2350-2361. doi: 10.1021/acsomega.3c06114. eCollection 2024 Jan 16. ACS Omega. 2024. PMID: 38250422 Free PMC article.
References
- Müller-Ehmsen J, et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol. 2002;34:107–116. - PubMed
- Zhang M, et al. Cardiomyocyte grafting for cardiac repair: Graft cell death and anti-death strategies. J Mol Cell Cardiol. 2001;33:907–921. - PubMed
- Shimizu T, et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res. 2002;90:e40. - PubMed
- Kelm JM, et al. Tissue-transplant fusion and vascularization of myocardial microtissues and macrotissues implanted into chicken embryos and rats. Tissue Eng. 2006;12:2541–2553. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL64387/HL/NHLBI NIH HHS/United States
- R01 HL064387/HL/NHLBI NIH HHS/United States
- P01 HL094374/HL/NHLBI NIH HHS/United States
- U24 DK076126/DK/NIDDK NIH HHS/United States
- R01 HL084642/HL/NHLBI NIH HHS/United States
- U24DK076126/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources